Found: 6
Select item for more details and to access through your institution.
Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice.
- Published in:
- Clinical & Translational Oncology, 2018, v. 20, n. 12, p. 1631, doi. 10.1007/s12094-018-1956-7
- By:
- Publication type:
- Article
Evaluation of waiting times for breast cancer diagnosis and surgical treatment.
- Published in:
- Clinical & Translational Oncology, 2018, v. 20, n. 10, p. 1345, doi. 10.1007/s12094-018-1867-7
- By:
- Publication type:
- Article
Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice.
- Published in:
- Clinical & Translational Oncology, 2018, v. 20, n. 7, p. 862, doi. 10.1007/s12094-017-1797-9
- By:
- Publication type:
- Article
Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-83622-1
- By:
- Publication type:
- Article
Real world evidence of adjuvant trastuzumab in HER2 positive early breast cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-34429-9
- By:
- Publication type:
- Article
Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case-control EpiGEICAM study.
- Published in:
- British Journal of Cancer, 2014, v. 111, n. 7, p. 1454, doi. 10.1038/bjc.2014.434
- By:
- Publication type:
- Article